Media: Webcast

Statement of Need
Given the availability of multiple treatment options, several questions emerge as to how to incorporate new therapies into the management of relapsed/refractory RCC: Is there an optimal agent, sequence, or combination of therapies? Is there a role for cytokine therapy in the current treatment paradigm for RCC? Are these agents active in non–clear cell RCC? Most importantly, can cure rates be improved when therapies are used earlier in the disease (neoadjuvant or adjuvant therapy)? Ongoing and planned clinical trials hope to provide insight into many of these questions. This educational initiative will provide participants with a review of the most recent advances in the treatment of renal cell carcinoma, including updates and outcomes of ongoing or recently published clinical trials, controversies, and research questions that have arisen as a result as well as consider some of the management issues that remain, all assimilated into a concise learning opportunity by experts in the field. The state-of-the-art strategies our experts will discuss will provide practitioners with the information needed to integrate therapeutic strategies into their patient care decisions. The end result will be to provide expertise to the oncology healthcare practitioner in order to improve outcomes for patients with renal cell carcinoma while minimizing adverse events and maintaining or improving patient overall quality of life.

Target Audience
The intended audience for this initiative is medical oncologists, hematologist-oncologists, urologists, pathologists, and allied healthcare professionals caring for patients with renal cell carcinoma.

PHYSICIAN CONTINUING EDUCATION
ACCREDITATION STATEMENT
Educational Concepts Group, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

DESIGNATION OF CREDIT
Educational Concepts Group, LLC designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credits for this activity. During the period June 5, 2009 through June 4, 2010 participants must: 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) complete the post-test and evaluation form. Participants must view each section in its entirety to receive full credit for this program.

CME CREDITS
A credit letter will be issued only upon successful completion of the post-test, with a score of 70% or higher, and will be available to view and print via the ECG website, www.educationalconcepts.net.

DISCLOSURE OF CONFLICT OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Educational Concepts Group, LLC (ECG) does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of ECG. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

DISCLOSURE OF FINANCIAL RELATIONSHIPS WITH ANY COMMERCIAL INTEREST
As a sponsor accredited by the ACCME, it is the policy of ECG to require that everyone who is in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest and identify and resolve all conflicts of interest prior to the educational activity. The ACCME defines “relevant financial relationships” as any amount occurring within the past 12 months.

Faculty who refuse to disclose relevant financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CE, and cannot have control of, or responsibility for, the development, management, presentation, or evaluation of the CE activity. For an individual with no relevant financial relationship(s), the participants must be informed that no relevant financial relationship(s) exist.

If ECG determines that a potential conflict of interest exists as a result of a personal financial relationship, mechanisms will be instituted to resolve this conflict prior to the activity. ECG has implemented a content validator role. That role is to ensure that the activity materials are fair-balanced, scientifically sound, and free of bias toward the commercial supporter(s) of the activity or manufacturers of products discussed in the activity.

In addition, faculty members are expected to disclose discussion of an unlabeled use of a commercial product, or an investigational use not yet approved for any purpose. ECG is committed to providing learners with high-quality, unbiased, and state-of-the-art education.

I. The following faculty members have declared relevant financial relationships:

II. The activity planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity.

HARDWARE/SOFTWARE/INTERNET REQUIREMENTS
Pentium 800 processor or greater, Windows 98/NT/2000/XP or Mac OS X, Microsoft Internet Explorer 5.5 or later, Windows Media Player 9.0 or later, 128 MB of RAM, Monitor settings: High color at 800 x 600 pixels, Sound card and speakers, Adobe^® Flash^® Player 8 or 9, Broadband connection, and Cookies enabled in your web browser.

PRIVACY POLICY & CONFIDENTIALITY
Educational Concepts Group, LLC makes reasonable efforts to ensure that privacy issues are handled responsibly. Educational Concepts Group, LLC does not sell or share your information with other organizations that are not directly involved in this process. If you have any concerns, please contact our meetings department directly at 1.866.933.1681.

Yes, I am interested in viewing the archived webcast. I have reviewed the information above.